Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Jazz Pharma Plc (JAZZ)

Jazz Pharma Plc (JAZZ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,491,807
  • Shares Outstanding, K 62,319
  • Annual Sales, $ 3,094 M
  • Annual Income, $ -329,670 K
  • 60-Month Beta 0.79
  • Price/Sales 2.96
  • Price/Cash Flow 6.41
  • Price/Book 2.54
Trade JAZZ with:

Options Overview Details

View History
  • Implied Volatility 46.41% ( +6.16%)
  • Historical Volatility 35.45%
  • IV Percentile 95%
  • IV Rank 87.24%
  • IV High 49.35% on 11/08/21
  • IV Low 26.31% on 06/16/21
  • Put/Call Vol Ratio 4.50
  • Today's Volume 11
  • Volume Avg (30-Day) 51
  • Put/Call OI Ratio 2.51
  • Today's Open Interest 13,200
  • Open Int (30-Day) 12,986

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 3.65
  • Number of Estimates 8
  • High Estimate 4.12
  • Low Estimate 3.00
  • Prior Year 3.29
  • Growth Rate Est. (year over year) +10.94%

Price Performance

See More
Period Period Low Period High Performance
1-Month
138.00 +6.90%
on 05/10/22
169.89 -13.17%
on 04/21/22
-16.55 (-10.09%)
since 04/18/22
3-Month
129.51 +13.91%
on 02/24/22
169.98 -13.21%
on 04/07/22
+9.63 (+6.98%)
since 02/18/22
52-Week
117.64 +25.40%
on 11/30/21
189.00 -21.95%
on 06/15/21
-27.57 (-15.75%)
since 05/18/21

Most Recent Stories

More News
Why Axsome Therapeutics Stock Got Mashed on Monday

Investors were hardly impressed with the closing of a rights deal.

AXSM : 31.13 (-7.30%)
JAZZ : 147.52 (-3.14%)
ImmunoGen (IMGN) Q1 Earnings and Sales Outpace Estimates

ImmunoGen (IMGN) reports a narrower-than-expected loss for first-quarter 2022. It also beats revenue estimates.

RHHBY : 40.3400 (-0.07%)
LLY : 295.19 (-2.06%)
JAZZ : 147.52 (-3.14%)
IMGN : 3.51 (-11.27%)
Alcon (ALC) to Report Q1 Earnings: What's in the Cards?

Strength in Vision Care with the addition of new products and recent acquisition is likely to have contributed to Alcon's (ALC) first-quarter performance.

VRTX : 252.35 (-3.62%)
ALC : 70.62 (-2.09%)
JAZZ : 147.52 (-3.14%)
CLVS : 0.7401 (-5.29%)
STERIS (STE) to Report Q4 Earnings: What's in the Cards?

Strength in Healthcare and AST arms is expected to have driven STERIS' (STE) fourth-quarter revenues.

VRTX : 252.35 (-3.62%)
JAZZ : 147.52 (-3.14%)
STE : 219.11 (-1.14%)
CLVS : 0.7401 (-5.29%)
JAZZ Q1 Earnings Miss, Sales Robust, 2022 Guidance Raised

JAZZ's product revenues grow in the first quarter on the back of strong demand for its new drugs and drugs added with the acquisition of GW Pharmaceuticals. It raises guidance on strong results.

JAZZ : 147.52 (-3.14%)
XNCR : 22.55 (-9.11%)
AXSM : 31.13 (-7.30%)
LYEL : 3.68 (-8.68%)
Top Stocks that Could Benefit from a Study of THCV

THCV, or tetrahydrocannabivarin may have the potential to help with energy, focus/attention, and eve appetite, weight/BMI. In fact, in a study of 900 adults aged 21 and older in the U.S., InMed Pharmaceuticals...

TLRY : 4.79 (-6.81%)
WEED.TO : 7.18 (-4.77%)
CGC : 5.59 (-5.09%)
JAZZ : 147.52 (-3.14%)
ABBV : 152.43 (-1.52%)
INM : 0.7800 (-6.04%)
Jazz Pharmaceuticals (JAZZ) Lags Q1 Earnings and Revenue Estimates

Jazz (JAZZ) delivered earnings and revenue surprises of -0.53% and 4.54%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

JAZZ : 147.52 (-3.14%)
SGTX : 0.7977 (-7.14%)
Onconova (ONTX) to Report Q1 Earnings: What's in the Cards?

Investors will watch for updates on its lead candidate narazaciclib when Onconova Therapeutics. (ONTX) reports first-quarter earnings.

VRTX : 252.35 (-3.62%)
JAZZ : 147.52 (-3.14%)
CLVS : 0.7401 (-5.29%)
ONTX : 1.1200 (-5.88%)
Viatris (VTRS) to Report Q1 Earnings: What's in the Cards?

Viatris' (VTRS) Q1 earnings might have been adversely impacted by competition in the complex generics business.

VRTX : 252.35 (-3.62%)
JAZZ : 147.52 (-3.14%)
CLVS : 0.7401 (-5.29%)
VTRS : 11.27 (-1.74%)
Why Jazz (JAZZ) is Poised to Beat Earnings Estimates Again

Jazz (JAZZ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

JAZZ : 147.52 (-3.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Jazz Pharmaceuticals is a specialty biopharmaceutical company with a focus in the areas of neuroscience & oncology. It derives the majority of its revenues from its sleep disorder drugs' Xywav & Xyrem. Both drugs are approved for treating cataplexy & excessive daytime sleepiness in narcolepsy patients....

See More

Key Turning Points

3rd Resistance Point 156.82
2nd Resistance Point 154.87
1st Resistance Point 151.20
Last Price 147.52
1st Support Level 145.58
2nd Support Level 143.63
3rd Support Level 139.96

See More

52-Week High 189.00
Fibonacci 61.8% 161.74
Fibonacci 50% 153.32
Last Price 147.52
Fibonacci 38.2% 144.90
52-Week Low 117.64

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar